Clinical Trials Logo

Stomach Neoplasms clinical trials

View clinical trials related to Stomach Neoplasms.

Filter by:

NCT ID: NCT05280665 Completed - Gastric Cancer Clinical Trials

Specialization in Gastric Cancer Surgery

Start date: February 14, 2022
Phase:
Study type: Observational

Specialization is having competent and effective knowledge on a subject, and the tendency towards specialization is increasing due to the fact that it increases the success in the follow-up and treatment process of diseases. It has been observed that specialization in cancer surgery provides significant improvement in clinical outcomes in recent years. In this study, the effect of specialization in gastric cancer surgery on clinical outcomes is being investigated.

NCT ID: NCT05265221 Completed - Gastric Neoplasm Clinical Trials

Learning Curve for Gastric Endoscopic Submucosal Dissection

Start date: March 1, 2022
Phase:
Study type: Observational

Endoscopic submucosal dissection (ESD) for early gastric cancer is a widely accepted treatment option of expanded indication worldwide. ESD is relatively difficult compared with endoscopic mucosal resection, thus, proper training is essential for the safe performance of the procedure. Thus, it is necessary to receive proper training in the procedure for safe performance of ESD. Previous studies reported that there was a learning curve in ESD training and preceptees needed to perform at least 30-40 procedures in order to master this technique. However, there is few study about the association between the clinical characteristics and competence level for gastric ESD.

NCT ID: NCT05259488 Completed - Gastric Cancer Clinical Trials

Preoperative Immunonutrition in Laparoscopic Total D2 Gastrectomy

Start date: January 1, 2014
Phase:
Study type: Observational

Immunonutrition (IN) appears to reduce infective complications and in-hospital length of stay (LOS) after gastrointestinal surgery. More specifically, it seems to be beneficial also in gastric cancer surgery. Potential benefits of combining preoperative IN (PIN) with protocols of enhanced recovery after surgery (ERAS) in reducing LOS in laparoscopic total gastrectomy are yet to be determined.

NCT ID: NCT05253430 Completed - Gastric Cancer Clinical Trials

D1 vs D2 Lymphadenectomy in Gastric Cancer

Start date: April 1990
Phase:
Study type: Observational

This study is a retrospective study with a propensity score-matched analysis in order to balance differences between patients with D1 and D2 lymphadenectomy for gastric cancer.The main aim is to analyse differences in the postoperative and oncological outcomes of patients with gastric cancer (GC) who underwent D1 and D2 gastrectomy.

NCT ID: NCT05219539 Completed - Gastric Cancer Clinical Trials

Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical Gastrectomy

ATP-LRG-1
Start date: November 11, 2021
Phase:
Study type: Observational

This study aims to evaluate the outcomes of the advanced training program for laparoscopic radical gastrectomy (ATP-LRG). The research subjects are the trainees who participated in this training program.

NCT ID: NCT05186402 Completed - Gastric Cancer Clinical Trials

Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case Series

Start date: January 1, 2016
Phase:
Study type: Observational

This is a retrospective study extending over a period of three years concerning patients with gastric adenocarcinoma hospitalized in the digestive cancer surgery and liver transplant service of the IBN ROCHD University Hospital Center in Casablanca. Evaluation from a series of 80 cases of gastric adenocarcinomas, follow-up to determine the prognostic factors influencing mortality, morbidity and survival.

NCT ID: NCT05181306 Completed - Gastric Cancer Clinical Trials

Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric Cancer

Start date: October 1, 2010
Phase:
Study type: Observational

This study is a retrospective, single-center, controlled and observation trial comparing robotic total gastrectomy with D2 lymph nodal dissection for locally advanced gastric cancer patients with laparoscopic procedure.

NCT ID: NCT05173909 Completed - Clinical trials for The Effect of BIS Closed-loop Target Control on Postoperative Operation

Effects of BIS Closed Loop Target Controlled Infusion on Perioperative Inflammatory Response and Prognosis of Elderly Patients Undergoing Laparoscopic Radical Gastrectomy for Gastric Cancer

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to find the elderly patients with laparoscopic gastric cancer radical is suitable the BIS closed round target control level of anesthesia depth of sedation, can decrease the elderly laparoscopic gastric cancer radical surgery in patients with perioperative inflammatory reaction, and reduce the incidence of perioperative pulmonary complications such as, for elderly patients with gastric cancer radical perioperative inflammation control to provide the reference and provide guidance for clinical anesthesia work.

NCT ID: NCT05130710 Completed - Gastric Cancer Clinical Trials

The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer

Start date: February 25, 2020
Phase:
Study type: Observational

This was a retrospective case-control study designed and conducted under the approval of the ethic committee of Tehran University of Medical Sciences. All patients with gastric cancer referring to Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran, during February 25th and December 25th 2020, were enrolled to the study.

NCT ID: NCT05125614 Completed - Gastric Cancer Clinical Trials

Gastric Cancer Survival Without Chemotherapy

Start date: May 1, 2020
Phase:
Study type: Observational

This study is observational study to analyze the actual overall survival of the patients who did not receive adjuvant chemotherapy after curative gastrectomy for gastric cancer. The investigators developed prediction model for the overall survival of these patients and validated.